Traditional studies in solid tumors have shown that CD4 TH cells sustain anti‐tumor activity by directing other leukocytes, enhancing tumor‐antigen presentation, and directly inhibiting tumor proliferation via interferon gamma (IFN‐γ) and tumor necrosis factor alpha (TNF‐α) [67]. This evidence concerns the gene CD4 and neoplasm.